Cash flow CorVel Corporation

Equities

CRVL

US2210061097

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 21:00:00 20/04/2026 BST			5-day change	1st Jan Change
54.72 ^USD	-2.25%		+0.77%	-19.14%

03-17	Corvel Insider Sold Shares Worth $432,702, According to a Recent SEC Filing	MT
02-17	Corvel Insider Sold Shares Worth $955,800, According to a Recent SEC Filing	MT

8ad5d7bacd92e1d450cfaf.9XKisdooMBEF3Aml7-7Ypo2rf_X2sTu5LEeguiTshDY.rC2PxKB-RmN9lmbJu9-p5L3qG8ak_lfheir40Qm19UKvF-z27XpbQjaKMQ

Published financial data: CORVEL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	553M	646M	719M	795M	896M
Total Revenues	553M	646M	719M	795M	896M
Cost of Goods Sold, Total	429M	494M	560M	624M	686M
Gross Profit	124M	152M	158M	172M	210M
Selling General & Admin Expenses, Total	64.45M	67.6M	73.7M	76.59M	88.9M
Other Operating Expenses, Total	64.45M	67.6M	73.7M	76.59M	88.9M
Operating Income	59.18M	84.51M	84.55M	95.1M	121M
EBT, Excl. Unusual Items	59.18M	84.51M	84.55M	95.1M	121M
EBT, Incl. Unusual Items	59.18M	84.51M	84.55M	95.1M	121M
Income Tax Expense	12.82M	18.1M	18.19M	18.85M	25.66M
Earnings From Continuing Operations	46.36M	66.41M	66.36M	76.25M	95.16M
Net Income to Company	46.36M	66.41M	66.36M	76.25M	95.16M
Net Income - (IS)	46.36M	66.41M	66.36M	76.25M	95.16M
Net Income to Common Incl Extra Items	46.36M	66.41M	66.36M	76.25M	95.16M
Net Income to Common Excl. Extra Items	46.36M	66.41M	66.36M	76.25M	95.16M
Per Share Items
Net EPS - Basic	0.86	1.25	1.28	1.48	1.85
Basic EPS - Continuing Operations	0.86	1.25	1.28	1.48	1.85
Basic Weighted Average Shares Outstanding	53.79M	53.26M	51.98M	51.37M	51.38M
Net EPS - Diluted	0.85	1.22	1.26	1.47	1.83
Diluted EPS - Continuing Operations	0.85	1.22	1.26	1.47	1.83
Diluted Weighted Average Shares Outstanding	54.5M	54.38M	52.78M	52.04M	51.99M
Normalized Basic EPS	0.69	0.99	1.02	1.16	1.47
Normalized Diluted EPS	0.68	0.97	1	1.14	1.45
Supplemental Items
EBITDA	82.61M	108M	110M	121M	150M
EBITA	59.61M	84.95M	84.98M	95.52M	121M
EBIT	59.18M	84.51M	84.55M	95.1M	121M
EBITDAR	98.7M	123M	123M	132M	160M
Effective Tax Rate - (Ratio)	21.66	21.42	21.51	19.82	21.24
Current Domestic Taxes	21.2M	15.8M	20.1M	22.17M	30.82M
Total Current Taxes	21.2M	15.8M	20.1M	22.17M	30.82M
Deferred Domestic Taxes	-8.38M	2.3M	-1.91M	-3.32M	-5.16M
Total Deferred Taxes	-8.38M	2.3M	-1.91M	-3.32M	-5.16M
Normalized Net Income	36.98M	52.82M	52.85M	59.44M	75.52M
Supplemental Operating Expense Items
General and Administrative Expenses	64.45M	67.6M	73.7M	76.59M	88.9M
Net Rental Expense, Total	16.09M	14.28M	12.83M	10.66M	9.85M
Stock-Based Comp., COGS (Total)	2.02M	2.06M	2.57M	2.8M	2.79M
Stock-Based Comp., G&A Exp. (Total)	2.96M	3.14M	2.99M	2.18M	2.92M
Total Stock-Based Compensation	4.98M	5.2M	5.56M	4.98M	5.71M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	140M	97.5M	71.33M	106M	171M
Total Cash And Short Term Investments	140M	97.5M	71.33M	106M	171M
Accounts Receivable, Total	64.72M	82.59M	81.03M	97.11M	104M
Total Receivables	64.72M	82.59M	81.03M	97.11M	104M
Prepaid Expenses	8.01M	12.76M	9.57M	9.25M	10.51M
Other Current Assets, Total	56.5M	72.15M	81.84M	90.31M	101M
Total Current Assets	269M	265M	244M	302M	387M
Gross Property Plant And Equipment	156M	158M	150M	140M	142M
Accumulated Depreciation	-67.74M	-76.02M	-73.62M	-67M	-71.45M
Net Property Plant And Equipment	88.04M	81.48M	76.8M	72.78M	70.12M
Long-term Investments	-	-	-	-	-
Goodwill	36.81M	36.81M	36.81M	36.81M	36.81M
Other Intangibles, Total	30.01M	31.48M	34.94M	37.99M	43.19M
Deferred Tax Assets Long-Term	613K	-	224K	3.54M	8.7M
Other Long-Term Assets, Total	345K	481K	1.38M	1.32M	454K
Total Assets	425M	415M	394M	455M	546M
Liabilities
Accounts Payable, Total	12.35M	14.08M	15.06M	16.41M	15.42M
Accrued Expenses, Total	57.11M	48.01M	35.68M	40.9M	46.84M
Current Portion of Leases	12.76M	13.35M	9.9M	8.86M	8.13M
Current Income Taxes Payable	1.22M	-	251K	221K	1.37M
Unearned Revenue Current, Total	22.51M	25.8M	26.98M	29.96M	30.81M
Other Current Liabilities	56.5M	70.13M	80.02M	88.14M	101M
Total Current Liabilities	162M	171M	168M	184M	204M
Long-Term Leases	41.9M	29.79M	23.86M	22.53M	19.95M
Deferred Tax Liability Non Current	-	1.69M	-	-	-
Total Liabilities	204M	203M	192M	207M	224M
Common Stock, Total	3K	3K	3K	3K	5K
Additional Paid In Capital	186M	202M	219M	234M	250M
Retained Earnings	599M	665M	732M	808M	903M
Treasury Stock	-564M	-655M	-748M	-794M	-832M
Total Common Equity	220M	212M	202M	248M	322M
Total Equity	220M	212M	202M	248M	322M
Total Liabilities And Equity	425M	415M	394M	455M	546M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	53.55M	52.47M	51.43M	51.37M	51.35M
ECS Total Common Shares Outstanding	53.63M	52.71M	51.51M	51.39M	51.36M
Book Value / Share	4.11	4.03	3.93	4.82	6.27
Tangible Book Value	154M	144M	130M	173M	242M
Tangible Book Value Per Share	2.86	2.73	2.53	3.36	4.71
Total Debt	54.66M	43.14M	33.76M	31.4M	28.08M
Net Debt	-85.05M	-54.36M	-37.57M	-74.17M	-143M
Debt Equivalent Oper. Leases	129M	114M	103M	85.3M	78.79M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	11.08M	11.08M	11.08M	11.12M	11.05M
Machinery, Total	66.71M	77.38M	68.25M	66.61M	65.43M
Full Time Employees	3.68K	4.23K	4.44K	4.87K	5.08K
Accumulated Allowance for Doubtful Accounts (Supple)	3.27M	2.56M	2.82M	4.24M	7.69M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	46.36M	66.41M	66.36M	76.25M	95.16M
Depreciation & Amortization - CF	23M	23.48M	24.7M	25.83M	29.15M
Amortization of Goodwill and Intangible Assets - (CF)	435K	435K	425K	423K	383K
Depreciation & Amortization, Total	23.44M	23.92M	25.12M	26.25M	29.54M
Asset Writedown & Restructuring Costs	590K	122K	415K	290K	443K
Stock-Based Compensation (CF)	4.98M	5.2M	5.56M	4.98M	5.71M
Provision and Write-off of Bad Debts	2.02M	158K	1.22M	1.83M	3.44M
Other Operating Activities, Total	-8.38M	2.3M	-1.91M	-3.32M	-5.16M
Change In Accounts Receivable	-976K	-18.02M	336K	-17.9M	-10.46M
Change In Accounts Payable	-3.36M	1.42M	-4.4M	1.32M	162K
Change in Other Net Operating Assets	29.7M	-14.28M	-10.42M	9.53M	8.47M
Cash from Operations	94.38M	67.22M	82.29M	99.24M	127M
Capital Expenditure	-17.24M	-29.82M	-26.32M	-29.24M	-35.76M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-17.24M	-29.82M	-26.32M	-29.24M	-35.76M
Issuance of Common Stock	12.03M	10.47M	11.53M	9.95M	11.07M
Repurchase of Common Stock	-32.67M	-90.08M	-93.68M	-45.71M	-37.6M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-20.64M	-79.62M	-82.14M	-35.76M	-26.54M
Net Change in Cash	56.49M	-42.21M	-26.18M	34.23M	65.02M
Supplemental Items
Cash Income Tax Paid (Refund)	20.76M	19.4M	19.99M	22.87M	28.1M
Levered Free Cash Flow	73.93M	22.18M	52.22M	54.85M	75.85M
Unlevered Free Cash Flow	73.93M	22.18M	52.22M	54.85M	75.85M
Change In Net Working Capital	-25.77M	29.94M	4.99M	6.58M	-838K

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.8	12.58	13.06	14.01	15.09
Return on Total Capital	13.14	19.91	21.51	23.08	24.01
Return On Equity %	22.61	30.69	32.02	33.9	33.41
Return on Common Equity	22.61	30.69	32.02	33.9	33.41
Margin Analysis
Gross Profit Margin %	22.37	23.54	22.02	21.59	23.42
SG&A Margin	11.66	10.46	10.26	9.63	9.93
EBITDA Margin %	14.95	16.78	15.26	15.26	16.79
EBITA Margin %	10.79	13.14	11.83	12.01	13.53
EBIT Margin %	10.71	13.08	11.77	11.96	13.49
Income From Continuing Operations Margin %	8.39	10.28	9.24	9.59	10.63
Net Income Margin %	8.39	10.28	9.24	9.59	10.63
Net Avail. For Common Margin %	8.39	10.28	9.24	9.59	10.63
Normalized Net Income Margin	6.69	8.17	7.35	7.47	8.43
Levered Free Cash Flow Margin	13.38	3.43	7.27	6.9	8.47
Unlevered Free Cash Flow Margin	13.38	3.43	7.27	6.9	8.47
Asset Turnover
Asset Turnover	1.31	1.54	1.78	1.87	1.79
Fixed Assets Turnover	4.87	7.62	9.08	10.63	12.53
Receivables Turnover (Average Receivables)	8.47	8.77	8.78	8.93	8.9
Short Term Liquidity
Current Ratio	1.66	1.55	1.45	1.64	1.9
Quick Ratio	1.26	1.05	0.91	1.1	1.35
Operating Cash Flow to Current Liabilities	0.58	0.39	0.49	0.54	0.62
Days Sales Outstanding (Average Receivables)	43.09	41.6	41.56	40.99	41.01
Average Days Payable Outstanding	11.7	9.76	9.49	9.23	8.47
Long Term Solvency
Total Debt/Equity	24.8	20.31	16.7	12.68	8.72
Total Debt / Total Capital	19.87	16.88	14.31	11.25	8.02
LT Debt/Equity	19.01	14.03	11.8	9.1	6.2
Long-Term Debt / Total Capital	15.23	11.66	10.11	8.08	5.7
Total Liabilities / Total Assets	48.11	48.85	48.68	45.53	41.03
Total Debt / EBITDA	0.55	0.35	0.28	0.24	0.18
Net Debt / EBITDA	-0.86	-0.44	-0.31	-0.56	-0.89
Total Debt / (EBITDA - Capex)	0.67	0.46	0.35	0.31	0.23
Net Debt / (EBITDA - Capex)	-1.04	-0.59	-0.39	-0.72	-1.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.68	16.93	11.19	10.68	12.61
Gross Profit, 1 Yr. Growth %	-1.82	23.05	4.04	8.49	22.15
EBITDA, 1 Yr. Growth %	-0.74	31.25	1.15	10.65	23.9
EBITA, 1 Yr. Growth %	-2.51	42.5	0.04	12.41	26.89
EBIT, 1 Yr. Growth %	-2.53	42.82	0.05	12.47	27.05
Earnings From Cont. Operations, 1 Yr. Growth %	-2.16	43.26	-0.07	14.9	24.8
Net Income, 1 Yr. Growth %	-2.16	43.26	-0.07	14.9	24.8
Normalized Net Income, 1 Yr. Growth %	-2.53	42.82	0.05	12.47	27.05
Diluted EPS Before Extra, 1 Yr. Growth %	0	43.53	3.01	16.71	24.49
Accounts Receivable, 1 Yr. Growth %	-1.59	27.6	-1.88	19.84	7.23
Net Property, Plant and Equip., 1 Yr. Growth %	-36.53	-7.45	-5.75	-5.22	-3.66
Total Assets, 1 Yr. Growth %	2.04	-2.24	-5.14	15.42	20.08
Tangible Book Value, 1 Yr. Growth %	25.38	-6.17	-9.5	32.53	40
Common Equity, 1 Yr. Growth %	16.18	-3.63	-4.81	22.49	30.02
Cash From Operations, 1 Yr. Growth %	16.77	-28.77	22.41	20.6	28.29
Capital Expenditures, 1 Yr. Growth %	-46.72	72.93	-11.73	11.09	22.28
Levered Free Cash Flow, 1 Yr. Growth %	116.51	-70	135.47	5.04	38.27
Unlevered Free Cash Flow, 1 Yr. Growth %	116.51	-70	135.47	5.04	38.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.68	4.46	14.03	10.94	11.64
Gross Profit, 2 Yr. CAGR %	-0.48	9.91	13.14	6.24	15.12
EBITDA, 2 Yr. CAGR %	-1.12	14.14	15.22	5.79	17.09
EBITA, 2 Yr. CAGR %	-1.91	17.87	19.4	6.04	19.43
EBIT, 2 Yr. CAGR %	-1.92	17.98	19.54	6.08	19.54
Earnings From Cont. Operations, 2 Yr. CAGR %	-0.37	18.39	19.65	7.15	19.75
Net Income, 2 Yr. CAGR %	-0.37	18.39	19.65	7.15	19.75
Normalized Net Income, 2 Yr. CAGR %	-1.92	17.98	19.54	6.08	19.54
Diluted EPS Before Extra, 2 Yr. CAGR %	1.81	19.8	21.59	9.65	20.51
Accounts Receivable, 2 Yr. CAGR %	-4.75	12.06	11.89	8.44	13.36
Net Property, Plant and Equip., 2 Yr. CAGR %	59.91	-23.36	-6.6	-5.49	-4.44
Total Assets, 2 Yr. CAGR %	15.57	-0.12	-3.7	4.64	17.73
Tangible Book Value, 2 Yr. CAGR %	9.77	8.46	-7.85	9.52	36.21
Common Equity, 2 Yr. CAGR %	6.37	5.81	-4.22	7.98	26.2
Cash From Operations, 2 Yr. CAGR %	9.55	-8.8	-6.63	21.5	24.39
Capital Expenditures, 2 Yr. CAGR %	6.25	-4.01	23.55	-0.98	16.55
Levered Free Cash Flow, 2 Yr. CAGR %	17.88	-19.41	-15.95	57.27	20.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.88	-19.41	-15.95	57.27	20.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.34	2.75	6.66	12.9	11.49
Gross Profit, 3 Yr. CAGR %	4.85	6.82	7.92	11.57	11.3
EBITDA, 3 Yr. CAGR %	5.84	8.67	9.63	13.68	11.51
EBITA, 3 Yr. CAGR %	7.56	11.1	11.6	17.02	12.58
EBIT, 3 Yr. CAGR %	7.3	11.17	11.67	17.13	12.65
Earnings From Cont. Operations, 3 Yr. CAGR %	9.1	12.45	11.89	18.05	12.74
Net Income, 3 Yr. CAGR %	9.1	12.45	11.89	18.05	12.74
Normalized Net Income, 3 Yr. CAGR %	7.3	11.17	11.67	17.13	12.65
Diluted EPS Before Extra, 3 Yr. CAGR %	10.89	14.16	13.92	19.94	14.47
Accounts Receivable, 3 Yr. CAGR %	-0.11	5	7.21	14.48	8.03
Net Property, Plant and Equip., 3 Yr. CAGR %	28.31	33.27	-17.89	-6.15	-4.88
Total Assets, 3 Yr. CAGR %	15.73	9.3	-1.82	2.29	9.55
Tangible Book Value, 3 Yr. CAGR %	14.15	4.18	2.11	4.02	18.86
Common Equity, 3 Yr. CAGR %	8.79	2.92	2.14	3.96	14.88
Cash From Operations, 3 Yr. CAGR %	14.94	-5.09	0.6	1.69	23.72
Capital Expenditures, 3 Yr. CAGR %	-14.6	24.98	-6.65	19.25	6.24
Levered Free Cash Flow, 3 Yr. CAGR %	38.48	-25.3	15.21	-9.47	50.67
Unlevered Free Cash Flow, 3 Yr. CAGR %	38.48	-25.3	15.21	-9.47	50.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.88	4.5	5.17	5.95	8.62
Gross Profit, 5 Yr. CAGR %	3.41	7.74	8.09	6.59	10.74
EBITDA, 5 Yr. CAGR %	4.59	9.62	9.5	7.51	12.56
EBITA, 5 Yr. CAGR %	5.29	12.31	12.15	9.05	14.67
EBIT, 5 Yr. CAGR %	5.14	12.19	12.04	9.1	14.76
Earnings From Cont. Operations, 5 Yr. CAGR %	10.2	17.64	13.21	10.3	14.97
Net Income, 5 Yr. CAGR %	10.2	17.64	13.21	10.3	14.97
Normalized Net Income, 5 Yr. CAGR %	5.14	12.19	12.04	9.1	14.76
Diluted EPS Before Extra, 5 Yr. CAGR %	12.26	19.37	15.06	12.33	16.58
Accounts Receivable, 5 Yr. CAGR %	1.61	5.62	4.53	6.36	9.63
Net Property, Plant and Equip., 5 Yr. CAGR %	25.63	16.9	13	16.15	-12.75
Total Assets, 5 Yr. CAGR %	14.04	12.02	7.53	7.41	5.58
Tangible Book Value, 5 Yr. CAGR %	18.51	14.8	4.78	6.28	14.59
Common Equity, 5 Yr. CAGR %	10.81	8.9	3.38	4.92	11.16
Cash From Operations, 5 Yr. CAGR %	12.96	5.25	5.77	4.76	9.51
Capital Expenditures, 5 Yr. CAGR %	0.57	-0.8	-1.01	13.87	2.02
Levered Free Cash Flow, 5 Yr. CAGR %	15.03	0.37	13.41	0.61	17.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.03	0.37	13.41	0.61	17.31